Ashraf Eassa
Long/short equity, contrarian, independent research, tech

Ultratech Ultrapainful

Ultratech (NASDAQ:UTEK) announced its third quarter earnings and they came in uglier than even the most bearish sell-side estimates were calling for. Indeed, while the sell side consensus for rev/EPS was $42.8M/$0.04, the results were downright ugly at $29.8M/($0.28). Management did its shareholders a serious disservice by not pre-announcing a miss of this magnitude. At this point, while more aggressive investors may be willing to take the risk and hold through on the expectations that the logic spending pause outlined in the original thesis will hold true, the shares are at best dead money over the next couple of months and the opportunity cost likely too high for fresh money at this time.

First, The Good News


Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details